Search Results 1071-1080 of 17083 for egfr

  1. Publications - Gang Zheng, M.D., Ph.D. - Mayo Clinic

    Clinical Validation of Coexisting Activating Mutations Within EGFR, Mitogen-Activated Protein Kinase, and Phosphatidylinositol 3-Kinase Pathways in Lung Cancers ...

  2. Gastroesophageal reflux disease (GERD) - Doctors and departments - Mayo Clinic

    Departments and specialties. Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, ...

  3. Dural arteriovenous fistulas - Doctors and departments - Mayo Clinic

    Learn about these rare, irregular connections that can occur between arteries and veins in the protective covering of the brain and spinal cord.

  4. Neurology - Clinical trials

    The Parkinson Progression Marker Initiative (PPMI) is a study to assess progression of clinical features, digital outcomes, and imaging, biologic and ...

  5. Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) - Doctors and departments - Mayo Clinic

    This complicated condition may be triggered by an infection. While there's no cure for ME/CFS, treatment focuses on easing symptoms.

  6. Gastroesophageal reflux disease (GERD) - Doctors and departments - Mayo Clinic

    Departments and specialties. Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, ...

  7. Gastroenterology and Hepatology - Clinical trials

    Rochester, Minn. The purpose of this study is to create a registry of obese patients who have been phenotyped to understand the heterogeneity of obesity. Celiac ...

  8. Effects of NNC0194-0499, Cagrilintide, And Semaglutide Alone Or Combined With Semaglutide On Liver Damage And Alcohol Use In Alcohol-Related Liver Disease - Mayo Clinic

    eGFR < 60 mL/min/1.73 m^2 as defined according to the CKD-EPI creatinine equation (KDIGO 2012) at V1. HbA1c > 80 mmol/mol (9.5%) at Vl. Platelet count ...

  9. Echocardiographic Measures of Pulmonary Vascular Distensibility and Effects on Lung Diffusing Capacity - Mayo Clinic

    The purpose of this study is to determine if the change in pulmonary vascular compliance with positional changes (upright, supine, and Trendelenburg position) ...

  10. A Phase I, Multi-Center, Open Label, Dose De-escalation and Expansion Study of Gemcitabine and Cisplatin with AG120 or Pemigatinib for Advanced Cholangiocarcinoma - Mayo Clinic

    Ivosidenib and pemigatinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Giving gemcitabine and cisplatin with ...